Phase 1 PK Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients

StatusCompleted
PhasePhase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Completed without a posted recruiting period
    • Primary completion date changed from estimate of Dec 2026 to Oct 9, 2026
    • Start date changed from estimate of Sep 2026 to Sep 21, 2026
    • Site contact updated
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a phase 1, single-dose, 2-period crossover study in healthy volunteers to compare the systemic pharmacokinetic (PK) profile of inhaled AERO-002 versus inhaled active comparator product.
Trial Details
NCT Number NCT07802730
Lead Sponsor AeroRx Therapeutics Inc.
Collaborators: Medicines Evaluation Unit Ltd
Conditions
(from sponsor)		 COPD (Chronic Obstructive Pulmonary Disease)
Related terms Pulmonary Disease, Chronic Obstructive, Respiratory Aspiration
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov